“���������������������������op������r���:za33���”的搜索结果，显示 91-100 项，共有 1325 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The aim of the study is to create a registry to prospectively collect pre-operative, during surgery and post-operative data, questionaries will assess (at ...

2. 血管中心- 临床试验- 妙佑医疗国际

   The purpose of this study will be collection of standard and routinely obtained data specifically in the preoperative evaluation; operative room ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R AML). The dose escalation (Part A) of the study will explore escalating intravenous doses of CC-96191 to estimate the MTD and/or RP2D of CC-96191 as ...

4. 外科 - 临床试验- 妙佑医疗国际

   ... operative hernia and operative complications. Mayo Clinic Upper Digestive Disease Survey. Rochester, Minn. The Mayo Clinic Upper Digestive Disease Survey has ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purposes of this study are to compare the functional connectivity in adolescent patients with Postural Orthostatic Tachycardia Syndrome (POTS) both with ...

7. 肺癌计划- 临床试验- 妙佑医疗国际

   This study is a Phase III, randomised, open label, multi-centre study assessing the efficacy and safety of MEDI4736 versus Standard of Care in NSCLC ...

8. 普通内科- 临床试验- 妙佑医疗国际

   探索针对健康生活方式、早期疾病检测、预防策略和成人不明原因症状诊断的服务。

9. 神经科- 临床试验- 妙佑医疗国际

   The purposes of this study are to compare the functional connectivity in adolescent patients with Postural Orthostatic Tachycardia Syndrome (POTS) both with ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...